 |
 |
I cannot see how an insurance company can classify a pharmaceutical product if it had been approved by the FDA and then in the United States Pharmacopeia (USP). The USP is the premier official compendium for all approved drugs in every state of the union. Yet you should first verify the status of the drug. Michel Margie Swindler << And that upset me for a number of reasons. First, how is Requip not a maintenance drug? Second, should an HMO be able to reclassify a drug as non-formulary in a unilateral action? And third, what does this ultimately mean for prescription drug coverage by Medicare? >>